awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26824542-7D68DA65-9597-40D6-A3D5-1728D374E912
Q26824542-7D68DA65-9597-40D6-A3D5-1728D374E912
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824542-7D68DA65-9597-40D6-A3D5-1728D374E912
How Long is Enough - Optimal Timing of Anti-HER2/neu Therapy in the Adjuvant Setting in Early Breast Cancer
P2860
Q26824542-7D68DA65-9597-40D6-A3D5-1728D374E912
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824542-7D68DA65-9597-40D6-A3D5-1728D374E912
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d9f2e75fa56b8ca2dac7a6be464166442df71d19
P2860
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.